{
    "ticker": "OPK",
    "name": "Opko Health, Inc.",
    "description": "Opko Health, Inc. is a diversified healthcare company that operates in the biotechnology and pharmaceutical sectors. Founded in 2007 and headquartered in Miami, Florida, Opko focuses on developing and delivering innovative healthcare solutions across various therapeutic areas, including diagnostics, pharmaceuticals, and biologics. The company's mission is to improve patient outcomes through advanced medical technologies and comprehensive healthcare services. Opko is known for its proprietary diagnostics platform, which includes the 4Kscore test for prostate cancer detection, and its growth hormone therapies for patients with growth hormone deficiency. In addition, Opko has a robust pipeline of drug candidates in various stages of clinical development. The company is committed to research and development, investing heavily in advancing its clinical programs and expanding its product offerings to meet the evolving needs of patients and healthcare providers. Opko aims to leverage its expertise and innovative approaches to deliver meaningful advancements in healthcare, ultimately striving to enhance the quality of life for patients worldwide.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals",
        "Diagnostics"
    ],
    "headquarters": "Miami, Florida, USA",
    "founded": "2007",
    "website": "https://www.opko.com",
    "ceo": "Phillip Frost",
    "social_media": {
        "twitter": "https://twitter.com/OpkoHealth",
        "linkedin": "https://www.linkedin.com/company/opko-health"
    },
    "investor_relations": "https://investors.opko.com",
    "key_executives": [
        {
            "name": "Phillip Frost",
            "position": "CEO"
        },
        {
            "name": "H. Robert M. Fuchs",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Diagnostics",
            "products": [
                "4Kscore Test",
                "Genetic Testing"
            ]
        },
        {
            "category": "Pharmaceuticals",
            "products": [
                "Human Growth Hormone",
                "Other Specialty Drugs"
            ]
        }
    ],
    "seo": {
        "meta_title": "Opko Health, Inc. | Innovative Healthcare Solutions",
        "meta_description": "Explore Opko Health, Inc., a leader in biotechnology and pharmaceuticals dedicated to improving patient outcomes through innovative diagnostics and therapeutics.",
        "keywords": [
            "Opko Health",
            "Biotechnology",
            "Pharmaceuticals",
            "Diagnostics",
            "4Kscore Test",
            "Growth Hormone"
        ]
    },
    "faq": [
        {
            "question": "What does Opko Health do?",
            "answer": "Opko Health develops and delivers innovative healthcare solutions in biotechnology, pharmaceuticals, and diagnostics."
        },
        {
            "question": "Who is the CEO of Opko Health?",
            "answer": "Phillip Frost is the CEO of Opko Health, Inc."
        },
        {
            "question": "Where is Opko Health headquartered?",
            "answer": "Opko Health is headquartered in Miami, Florida, USA."
        },
        {
            "question": "What are Opko's main products?",
            "answer": "Opko's main products include the 4Kscore test for prostate cancer and human growth hormone therapies."
        },
        {
            "question": "When was Opko Health founded?",
            "answer": "Opko Health was founded in 2007."
        }
    ],
    "competitors": [
        "AMGN",
        "REGN",
        "VRTX",
        "PFE"
    ],
    "related_stocks": [
        "JNJ",
        "MRK",
        "ABBV",
        "BMY"
    ]
}